News

MedVasc and the Solutio™ catheter system were recently featured in Venous News, highlighting the company’s ongoing development efforts and the clinical need Solutio is designed to address. Solutio is a novel catheter technology being developed to support the delivery of tumescent anesthesia from inside the vein during endothermal treatment…

MedVasc has been selected to participate in Innovate Nordics 2026, a prestigious accelerator program hosted by the Swedish-American Chamber of Commerce in New York in partnership with EY. The program brings together leading Nordic life science companies preparing for expansion into the U.S. market. Innovate Nordics provides participating companies…

MedVasc is pleased to announce that the company’s founder and Chief Medical Officer, Dr. Michael Åkesson, has been named this year’s Swedish Honorary Member of the Seldinger Society. The Seldinger Society, named after Swedish radiologist Sven-Ivar Seldinger, recognizes individuals who have made significant contributions to the advancement of interventional…

MedVasc AB has successfully completed production and testing activities in accordance with its previously communicated plan. In parallel, the company closed a new financing round at the end of 2025, raising SEK 24 million through subscriptions exclusively from existing shareholders. The strong participation from current owners demonstrates continued confidence…

One of Only 10 Startups Chosen from 86 Applicants to Pitch Before Leading Central European MedTech Investors Lund, Sweden, May 6, 2025 – MedVasc was selected to present at MedTech Pitch Day 2025, hosted by High-Tech Gründerfonds (HTGF), Germany’s largest investment fund for early-stage startups. Out of 86 high-potential…